56.95
BATS BZX Real-Time Price
As of 3:08pm ET
 -1.03 / -1.78%
Today’s Change
52.49
Today|||52-Week Range
63.62
+0.28%
Year-to-Date
Pfizer's Prevenar Cleared in the EU for New Indication - Analyst Blog
Mar 05 / Zacks.com
Dow Jones (DJIA) Today: Merck (MRK) Lower
Feb 27 / TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Higher
Mar 05 / TheStreet.com
Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog
Feb 27 / Zacks.com
Centerview builds record on pharma deals
Mar 05 / FT.com
The 3 Biggest Disappointments This Earnings Season
Feb 25 / MotleyFool.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
Hospira and Celltrion launch biosimilars
Feb 24 / FT.com
Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
Mar 04 / Zacks.com
Merck Strikes Deal with NGM to Develop Novel Biologics - Analyst Blog
Feb 24 / Zacks.com
Merck predicts flat earnings for 2015
Mar 03 / FT.com
Agilent-ONO Companion Diagnostics Aim - Analyst Blog
Feb 23 / Zacks.com
Stock Market News for March 02, 2015 - Market News
Mar 02 / Zacks.com
Eli Lilly Extends Phase III Cholesterol Study by Six Months - Analyst Blog
Feb 20 / Zacks.com
Fast Money Picks For March 2
Mar 01 / Benzinga
What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog
Feb 20 / Zacks.com
Billionaire George Soros Just Dumped These 3 Dividend Stocks
Mar 01 / MotleyFool.com
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Notic...
Feb 28 / MotleyFool.com
Investor flows reignite corporate bond issuance
Feb 06 / FT.com
Which Cancer Immunotherapy Will Be the Most Successful?
Feb 28 / MotleyFool.com
Merck defends children's vaccines after measles outbreak
Feb 04 / FT.com
Dow 30 Stock Roundup: Home Depot Beats, Chevron Issues $6B in Bonds - Analyst Blog
Feb 27 / Zacks.com
Stocks: 4 things to know before the open
Feb 04 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account